PET Imaging as a Tool for Assessing COVID-19 Brain Changes.
PET radiotracers
SARS-CoV-2
neurological manifestations
Journal
Trends in neurosciences
ISSN: 1878-108X
Titre abrégé: Trends Neurosci
Pays: England
ID NLM: 7808616
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
15
10
2020
accepted:
19
10
2020
pubmed:
3
11
2020
medline:
15
12
2020
entrez:
2
11
2020
Statut:
ppublish
Résumé
A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.
Identifiants
pubmed: 33131922
pii: S0166-2236(20)30243-5
doi: 10.1016/j.tins.2020.10.010
pmc: PMC7580682
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
935-938Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Lancet Neurol. 2020 Oct;19(10):804-805
pubmed: 32949534
Q J Nucl Med Mol Imaging. 2017 Dec;61(4):414-428
pubmed: 28750497
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33433624
Annu Rev Biomed Eng. 2019 Jun 4;21:551-581
pubmed: 31167104
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):592-595
pubmed: 32728799
Mol Imaging. 2018 Jan-Dec;17:1536012118792317
pubmed: 30203712
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
Eur J Neurol. 2020 Dec;27(12):2651-2657
pubmed: 32881133
Lancet Neurol. 2020 Nov;19(11):919-929
pubmed: 33031735
Radiology. 2020 Nov;297(2):E242-E251
pubmed: 32544034